Recently, Canadian, US and European health regulatory agencies issued warnings about an increased risk of stroke and death in elderly patients with dementia receiving atypical antipsychotics. Assessing both randomised and non-randomised evidence, this systematic review found conflicting findings, particularly for risperidone. More research is needed to better inform clinical practice. © 2008 Bentham Science Publishers Ltd.
File in questo prodotto:
Non ci sono file associati a questo prodotto.